Results
|
1.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
|
2.
|
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2020
Citation: - Jacc: Cardiovascular Interventions. 13(11):1343-1353, 2020 06 08.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
3.
|
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
|
|
4.
|
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
5.
|
Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis. MedStar authors:
Year: 2017
Citation: - JAMA Cardiology. 2(12):1303-1313, 2017 12 01.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Batchelor W, Chandrasekhar J, Davis S, Gigliotti OS, Giugliano G, Haghighat A, Horwitz PA, Kandzari DE, Lopez M, Mehran R, Othman I, Singh S, Tami L, Thompson CA, Underwood P, Wang JC
|
|
6.
|
Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents. MedStar authors:
- Kitabata, Hironori
- Laynez-Carnicero, Ana
- Loh, Joshua P
- Pichard, Augusto D
- Sardi, Gabriel L
- Satler, Lowell F
- Torguson, Rebecca
- Waksman, Ron
- Xue, Zhenyi
Year: 2014
Citation: - Cardiovascular Revascularization Medicine. 15(2):86-91, 2014 Mar.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
All authors: - Kitabata H, Laynez-Carnicero A, Loh JP, Pichard AD, Sardi GL, Satler LF, Torguson R, Waksman R, Xue Z
|